• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 CSF-1R 抑制在帕金森病动物模型中对小胶质细胞耗竭的神经保护作用。

Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson's Animal Model.

机构信息

Division of Applied RI, Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul, 01812, South Korea.

Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon, South Korea.

出版信息

Mol Imaging Biol. 2020 Aug;22(4):1031-1042. doi: 10.1007/s11307-020-01485-w.

DOI:10.1007/s11307-020-01485-w
PMID:32086763
Abstract

PURPOSE

Neuroinflammation in Parkinson's disease (PD) is known to play a pivotal role in progression to neuronal degeneration. It has been reported that colony-stimulation factor 1 receptor (CSF-1R) inhibition can effectively deplete microglia. However, its therapeutic efficacy in PD is unclear still now.

PROCEDURES

To elucidate this issue, we examined the contribution of microglial depletion to PD by behavioral testing, positron emission tomography (PET) imaging, and immunoassays in sham, PD, and microglial depletion PD model (PLX3397 was administered to PD groups, with n = 6 in each group).

RESULTS

The microglial depletion in PD model showed improved sensory motor function and depressive-like behavior. NeuroPET revealed that PLX3397 treatment resulted in partial recovery of striatal neuro-inflammatory functions (binding values of [F]DPA-174 for PD, 1.47 ± 0.12, p < 0.01 vs. for PLX3397 in PD: 1.33 ± 0.26) and the dopaminergic (binding values of F-FP-CIT for PD, 1.32 ± 0.07 vs. for PLX3397 in PD: 1.54 ± 0.10, p < 0.01) and glutamatergic systems (binding values of [F]FPEB for PD: 9.22 ± 0.54 vs. for PLX3397 Tx in PD: 9.83 ± 0.96, p > 0.05). Western blotting for microglia showed similar changes.

CONCLUSION

Microglial depletion has inflammation-related therapeutic effects, which have beneficial effects on motor and nonmotor symptoms of PD.

摘要

目的

帕金森病(PD)中的神经炎症被认为在神经元变性进展中起关键作用。据报道,集落刺激因子 1 受体(CSF-1R)抑制可有效耗尽小胶质细胞。然而,其在 PD 中的治疗效果尚不清楚。

过程

为了阐明这个问题,我们通过行为测试、正电子发射断层扫描(PET)成像和免疫测定检查了小胶质细胞耗竭对 PD 的贡献,在假手术、PD 和小胶质细胞耗竭 PD 模型中进行了检查(PLX3397 给予 PD 组,每组 n=6)。

结果

PD 模型中的小胶质细胞耗竭显示出改善的感觉运动功能和抑郁样行为。神经 PET 显示,PLX3397 治疗导致纹状体神经炎症功能部分恢复([F]DPA-174 的结合值为 PD,1.47±0.12,p<0.01,与 PD 中的 PLX3397 相比:1.33±0.26)和多巴胺能(F-FP-CIT 的结合值为 PD,1.32±0.07,与 PD 中的 PLX3397 相比:1.54±0.10,p<0.01)和谷氨酸能系统([F]FPEB 的结合值为 PD:9.22±0.54,与 PD 中的 PLX3397 Tx 相比:9.83±0.96,p>0.05)。小胶质细胞的 Western 印迹显示出相似的变化。

结论

小胶质细胞耗竭具有与炎症相关的治疗效果,对 PD 的运动和非运动症状有有益影响。

相似文献

1
Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson's Animal Model.评估 CSF-1R 抑制在帕金森病动物模型中对小胶质细胞耗竭的神经保护作用。
Mol Imaging Biol. 2020 Aug;22(4):1031-1042. doi: 10.1007/s11307-020-01485-w.
2
Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.小胶质细胞的部分耗竭和再群体化在急性 MPTP 帕金森病小鼠模型中具有不同的影响。
Cell Prolif. 2021 Aug;54(8):e13094. doi: 10.1111/cpr.13094. Epub 2021 Jul 26.
3
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.抑制JAK/STAT信号通路可预防α-突触核蛋白诱导的神经炎症和多巴胺能神经退行性变。
J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.
4
Short-Term Colony-Stimulating Factor 1 Receptor Inhibition-Induced Repopulation After Stroke Assessed by Longitudinal F-DPA-714 PET Imaging.通过纵向 F-DPA-714 PET 成像评估中风后短期集落刺激因子 1 受体抑制诱导的再群体化。
J Nucl Med. 2022 Sep;63(9):1408-1414. doi: 10.2967/jnumed.121.263004. Epub 2022 Feb 3.
5
Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [F]DPA-714 Targeting TSPO.帕金森病大鼠早期模型中活化的小胶质细胞:通过靶向 TSPO 的 [F]DPA-714 PET-MRI 成像揭示。
ACS Chem Neurosci. 2023 Jun 7;14(11):2183-2192. doi: 10.1021/acschemneuro.3c00202. Epub 2023 May 3.
6
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.小胶质细胞活化导致鱼藤酮诱导的小鼠帕金森病模型认知功能障碍。
J Neuroinflammation. 2021 Jan 5;18(1):4. doi: 10.1186/s12974-020-02065-z.
7
Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.纹状体 12 个亚区的详细 PET 分析:帕金森病患者多巴胺转运体丢失与非运动症状之间缺乏关联。
Neurol Sci. 2019 Feb;40(2):311-317. doi: 10.1007/s10072-018-3632-7. Epub 2018 Nov 10.
8
Increased microglial activation in patients with Parkinson disease using [F]-DPA714 TSPO PET imaging.使用 [F]-DPA714 TSPO PET 成像技术观察到帕金森病患者的小胶质细胞激活增加。
Parkinsonism Relat Disord. 2021 Jan;82:29-36. doi: 10.1016/j.parkreldis.2020.11.011. Epub 2020 Nov 17.
9
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.小胶质细胞、炎症和帕金森病进展猴模型中的肠道微生物群反应:病例系列。
Neurobiol Dis. 2020 Oct;144:105027. doi: 10.1016/j.nbd.2020.105027. Epub 2020 Jul 24.
10
Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.骨髓间充质干细胞移植治疗帕金森病大鼠模型后多巴胺转运体结合活性的改善:采用 F-18 FP-CIT 进行小动物正电子发射断层扫描研究。
Eur Radiol. 2015 May;25(5):1487-96. doi: 10.1007/s00330-014-3549-3. Epub 2014 Dec 11.

引用本文的文献

1
An update on novel and emerging therapeutic targets in Parkinson's disease.帕金森病中新的和新兴治疗靶点的研究进展。
Metab Brain Dis. 2024 Aug;39(6):1213-1225. doi: 10.1007/s11011-024-01390-z. Epub 2024 Jul 27.
2
Preclinical evaluation of [F]FP-CIT, the radiotracer targeting dopamine transporter for diagnosing Parkinson's disease: pharmacokinetic and efficacy analysis.[F]FP-CIT的临床前评估,一种用于诊断帕金森病的靶向多巴胺转运体的放射性示踪剂:药代动力学和疗效分析。
EJNMMI Res. 2024 Jul 3;14(1):59. doi: 10.1186/s13550-024-01121-6.
3
Imaging Procedure and Clinical Studies of [F]FP-CIT PET.

本文引用的文献

1
Publisher Correction: Sensory attenuation in Parkinson's disease is related to disease severity and dopamine dose.出版商更正:帕金森病中的感觉衰减与疾病严重程度和多巴胺剂量有关。
Sci Rep. 2018 Nov 22;8(1):17429. doi: 10.1038/s41598-018-35439-8.
2
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.炎症小体抑制可预防小鼠 α-突触核蛋白病和多巴胺能神经退行性变。
Sci Transl Med. 2018 Oct 31;10(465). doi: 10.1126/scitranslmed.aah4066.
3
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
[F]FP-CIT正电子发射断层扫描的成像程序与临床研究
Nucl Med Mol Imaging. 2024 Jun;58(4):185-202. doi: 10.1007/s13139-024-00840-x. Epub 2024 Jan 17.
4
Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition.α-突触核蛋白包涵体反应性小胶质细胞对 CSF1R 抑制有抗性。
J Neuroinflammation. 2024 Apr 25;21(1):108. doi: 10.1186/s12974-024-03108-5.
5
Deplete and repeat: microglial CSF1R inhibition and traumatic brain injury.消耗并重复:小胶质细胞集落刺激因子1受体抑制与创伤性脑损伤
Front Cell Neurosci. 2024 Feb 21;18:1352790. doi: 10.3389/fncel.2024.1352790. eCollection 2024.
6
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson's disease mouse model.小胶质细胞抑制可减轻帕金森病小鼠模型中α-突触核蛋白的传播和神经退行性变。
NPJ Parkinsons Dis. 2024 Feb 2;10(1):32. doi: 10.1038/s41531-024-00640-2.
7
Myeloid-specific blockade of notch signaling alleviates dopaminergic neurodegeneration in Parkinson's disease by dominantly regulating resident microglia activation through NF-κB signaling.Notch 信号的髓系特异性阻断通过 NF-κB 信号为主地调节驻留小胶质细胞的激活,从而减轻帕金森病中的多巴胺能神经退行性变。
Front Immunol. 2023 Aug 23;14:1193081. doi: 10.3389/fimmu.2023.1193081. eCollection 2023.
8
A 14-day pulse of PLX5622 modifies α-synucleinopathy in preformed fibril-infused aged mice of both sexes.PLX5622 为期 14 天的脉冲给药可改变雌雄两性预形成纤维输注的老年小鼠的 α-突触核蛋白病。
Neurobiol Dis. 2023 Aug;184:106196. doi: 10.1016/j.nbd.2023.106196. Epub 2023 Jun 12.
9
Novel therapeutic targets to halt the progression of Parkinson's disease: an in-depth review on molecular signalling cascades.阻止帕金森病进展的新型治疗靶点:对分子信号级联的深入综述
3 Biotech. 2023 Jul;13(7):218. doi: 10.1007/s13205-023-03637-5. Epub 2023 May 30.
10
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis.小胶质细胞表达的 I 型代谢型谷氨酸受体在健康和疾病中的生理病理学作用,重点是肌萎缩侧索硬化症。
Int J Mol Sci. 2023 Mar 9;24(6):5240. doi: 10.3390/ijms24065240.
全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
4
NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.NMDA 拮抗剂治疗帕金森病的非运动症状。
Transl Psychiatry. 2018 Jun 15;8(1):117. doi: 10.1038/s41398-018-0162-2.
5
Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain.靶向集落刺激因子 1 受体抑制剂的巨噬细胞和小胶质细胞激活是治疗损伤触发的神经性疼痛的有效策略。
Mol Pain. 2018 Jan-Dec;14:1744806918764979. doi: 10.1177/1744806918764979.
6
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.CSF1R 激酶抑制剂 BLZ945 可增强脑区特异性髓鞘再生和预防脱髓鞘。
Acta Neuropathol Commun. 2018 Feb 15;6(1):9. doi: 10.1186/s40478-018-0510-8.
7
Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer.β淀粉样蛋白病理降低了阿尔茨海默病小鼠模型中大脑 mGluR5 的密度。
Neuropharmacology. 2018 May 1;133:512-517. doi: 10.1016/j.neuropharm.2018.02.003. Epub 2018 Feb 7.
8
Depletion of microglia augments the dopaminergic neurotoxicity of MPTP.小胶质细胞耗竭增强了 MPTP 的多巴胺能神经毒性。
FASEB J. 2018 Jun;32(6):3336-3345. doi: 10.1096/fj.201700833RR. Epub 2018 Jan 22.
9
Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.6-OHDA 致急性帕金森病及左旋多巴诱导异动症大鼠模型中 mGluR5 结合潜能和谷氨酰胺浓度的改变。
Neurobiol Aging. 2018 Jan;61:82-92. doi: 10.1016/j.neurobiolaging.2017.09.006. Epub 2017 Sep 21.
10
Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.小胶质细胞可能通过选择性消除苍白球谷氨酸能突触来补偿实验性帕金森病中多巴胺能神经元的丢失。
Glia. 2017 Nov;65(11):1833-1847. doi: 10.1002/glia.23199. Epub 2017 Aug 24.